12.12.23 -- Using Bayesian Statistics To Optimize Clinical Trial Supply

Learn about risk assessment strategies for clinical studies, including protocol requirements, drug characteristics, packaging specifications, and patient compliance concerns.

Explore how interactive response technologies (IRTs) built around microservices models can provide faster initial builds, more rapid change management, and improved built-in test automation.

Learn how to assess a CDMO’s capabilities and experience in the handling of potent drug substances and their capacity to provide support for clinical and commercial supply.

Discover how partnering with the right team can seamlessly integrate smart packaging into clinical studies, creating a patient-centric trial experience that maintains adherence to study protocols.

One of the most significant changes in the new EU regulation is Annex VI, which covers changes in the labelling requirements for investigational medical products (IMPs). So, what are the implications of these changes and how will they affect outer immediate packaging? 

Explore the common challenges faced by biopharma organizations with regards to supply chain management and offers insight into solutions by leveraging the RTSM/IRT.

Delve into a data-driven approach to assess the volume and value of cold chain medicines by combining IQVIA audit data with publicly available data.

Clinical trials can be completely derailed by the absence of a single component, a lack of clarity in labelling, or errors in temperature-controlled logistics.